Durac, Beverlyn B.
HRN: 11-42-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2025
CEFTRIAXONE 1G (VIAL)
10/02/2025
10/03/2025
IVT
2gma
OD
S/p Pelvic Lap
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes